PCRX vs AMLX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 08, 2026
PCRX
AMLX
Investment Advisor Scores
AMLX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | AMLX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.8717 | 2.7739 | AMLX |
| PEG Ratio | 0.9877 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | -99.6% | PCRX |
| Earnings Growth | -30.0% | 0.0% | AMLX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.9/100 | 38.5/100 | PCRX |
| Profit Margin | 2.0% | 0.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | PCRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (17.9% over 20 days), RSI 82
AMLX
NeutralMixed signals - no dominant trend phase, RSI 63
Fundamentals Snapshot
| Metric | PCRX | AMLX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | -29.6 |
| Trailing P/E | 39.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -1.0% |
| Gross Margin | 0.8% | 139.0% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 0.93 | -1.43 |
| Dividend Yield | — | — |